Ventricular Arrhythmia Risk Stratification Among Patients With Cardiac Resynchronization Therapy Devices [0.03%]
心脏再同步治疗装置患者的室性心律失常风险分层
Nobuhiko Ueda,Kohei Ishibashi,Takashi Noda et al.
Nobuhiko Ueda et al.
Background: Patients with left ventricular (LV) dysfunction have a higher risk of ventricular arrhythmia (VA) compared with those without, and are candidates for implantable cardioverter defibrillator (ICD). Response to c...
Clinical Significance of Cardiac Troponin I Elevation in Detecting Immune Checkpoint Inhibitor-Induced Myocarditis [0.03%]
检测免疫检查点抑制剂诱导心肌炎的临床意义--心脏肌钙蛋白I升高的作用
Masayoshi Oikawa,Fumika Haga,Tetsuya Tani et al.
Masayoshi Oikawa et al.
Background: Immune checkpoint inhibitors (ICIs) enhance T-cell activity against cancer, but can cause immune-related adverse events, including myocarditis, a rare yet potentially fatal complication. Cardiac troponin I (cT...
Circadian Variability and Its Influence on Infarct Size and Clinical Outcome Among Japanese Patients With Acute Myocardial Infarction [0.03%]
急性心肌梗死患者的昼夜变化及其对日本患者梗死面积和临床结局的影响
Tetsufumi Motokawa,Satoshi Honda,Satoshi Ikeda et al.
Tetsufumi Motokawa et al.
Background: There is significant circadian variation in the frequency of myocardial infarction onset, with a notable increase during the early morning. However, it remains unclear whether this circadian rhythm influences ...
Akihiro Hirashiki,Atsuya Shimizu
Akihiro Hirashiki
Heart failure with preserved ejection fraction (HFpEF) is becoming increasingly prevalent in aging societies. A recent multicenter cohort study in Japan demonstrated that cardiac rehabilitation (CR) significantly improves the prognosis of p...
Combination Therapy With Clarithromycin and Montelukast Suppresses the Progression of Aortic Aneurysms in Mice With Chronic Obstructive Pulmonary Disease [0.03%]
克拉霉素与蒙特鲁卡斯特联合治疗可抑制慢性阻塞性肺疾病小鼠主动脉瘤进展
Satoshi Yuhara,Yuji Narita,Aika Yamawaki-Ogata et al.
Satoshi Yuhara et al.
Background: Chronic obstructive pulmonary disease (COPD) is a known risk factor for aortic aneurysm (AA) enlargement and rupture. This study investigated the effects of clarithromycin (CAM) and montelukast (Mont), which a...
Prognostic Utility of Left Ventricular Ejection Fraction in Patients Undergoing Transcatheter Aortic Valve Implantation - A Systematic Review and Meta-Analysis [0.03%]
经导管主动脉瓣植入患者的左心室射血分数预后价值-系统回顾和meta分析
Yosuke Nabeshima,Tetsuji Kitano,Yoshiko Sakamoto et al.
Yosuke Nabeshima et al.
Background: Left ventricular ejection fraction (LVEF) is widely used to assess systolic function and to predict cardiovascular outcomes, but its prognostic role in patients undergoing transcatheter aortic valve implantati...
Current Return-to-Work Outcomes and Barriers Among Patients With Cardiovascular Disease Undergoing Cardiac Rehabilitation - A Questionnaire-Based Study [0.03%]
心脏病患者心脏康复治疗的现况及影响返工的危险因素-基于问卷调查的一项研究
Kei Imaoka,Junya Tanabe,Akihito Noguchi et al.
Kei Imaoka et al.
Background: Many patients with cardiovascular disease show no obvious physical disability after hospital discharge, making it difficult to recognize functional decline and adapt appropriate accommodations. Therefore, this...
Iatrogenic Left Ventricular Outflow Tract to Left Atrium Fistula Mimicking Mitral Valve Prolapse [0.03%]
医源性左心室流出道至左心耳瘘管伴二尖瓣脱垂样改变
Hiroki Okamoto,Atsushi Hayashi,Misato Kodama et al.
Hiroki Okamoto et al.
Alteration in Carotid Arterial Stiffness During Passive Leg Raising May Reflect Vascular Endothelial Function [0.03%]
改良的颈动脉顺应性试验可评估血管内皮功能下降患者的压力感受性心搏出量反应性
Kazunori Okada,Masahiro Nakabachi,Yasuhiro Hayashi
Kazunori Okada
Background: Flow-mediated dilation (FMD) is the established parameter of endothelial function but requires skill and specialized equipment. This study aimed to investigate whether changes in carotid artery ultrasound para...
Real-World Outcomes of Patients With Non-Valvular Atrial Fibrillation on Anticoagulants Ineligible for Phase III Trials of Direct Oral Anticoagulants - A Retrospective Cohort Study [0.03%]
非瓣膜性房颤口服直接抗凝药物III期临床试验排除患者的预后：一项回顾性队列研究
Mayumi Higa,Takeshi Morimoto,Masayuki Ikeda et al.
Mayumi Higa et al.
Background: Many patients with non-valvular atrial fibrillation (NVAF) on direct oral anticoagulants (DOACs) in real-world practice were ineligible for DOAC phase III trials. We aimed to determine the proportion of Japane...